Category: Gastrointestinal Stromal Tumors

VEENAT is the product that has redefined the oncology landscape and the market dynamics in favour of the patients in India. The first targeted therapy to be launched at a fractional price of the innovator. The first brand to spell AFFORDABILITY in oncology and to take the survival benefits across to the patients irrespective of their economic strata.

This principle of NATCO, that “No patient goes without medicine for want of money” set the trend of affordable pricing and patient assistance in the Indian oncology market. Thousands of bottles of free Veenat do not merely represent the brand/marketing statistics, but it portrays the survival of thousands of CML patients and the gratitude of oncologists who treated them. VEENAT is more than a blockbuster for the patients and the clinicians.